Weight Loss
At Bodysculpt, we offer advanced weight loss solutions using the latest medical advances, including Semaglutide and Tirzepatide, to help you achieve and maintain your ideal weight.
Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) agonist miming the natural GLP-1 produced in the gut. It enhances insulin production, which lowers blood sugar and reduces glucagon secretion. This medication effectively diminishes appetite and reduces overall food intake by delaying gastric emptying. Additionally, it influences brain regions responsible for pleasure eating, altering the psychological patterns associated with food consumption.
Semaglutide is the active ingredient in Ozempic, widely recognized for its benefits in diabetes management and, when used off-label, for significant weight loss.
Tirzepatide
Known commercially as Mounjaro, this drug is FDA-approved for weight loss. It has a dual incretin hormone action, targeting GIP and GLP-1 receptors in the gut. This dual action curbs appetite, enhances feelings of fullness and alters food-related thought processes.
Clinical studies have shown that Tirzepatide can lead to more significant weight loss and increased satiety than Semaglutide.
Retatrutide
Retatrutide is an investigational, next-generation weight management medication designed to support significant and sustained weight loss. It is a triple agonist, meaning it targets three key metabolic hormone receptors — GLP-1, GIP and glucagon — to enhance appetite control, regulate blood sugar and promote fat metabolism.
By leveraging multiple pathways, Retatrutide may offer greater weight loss and metabolic benefits compared to single or dual-agonist treatments.
Medications are available at Bodysculpt in their generic, compounded forms, providing a cost-effective solution for weight loss and body optimization. These treatments are approved for chronic weight management in individuals who are overweight, with a BMI of 27 or greater.